Diabetes
From the Journals
Meta-analysis confirms neuroprotective benefit of metformin
Metformin, the most commonly prescribed antidiabetic drug, may be neuroprotective, while diabetes is associated with an excess risk of...
From the Journals
Bariatric surgery cuts cardiovascular events, even in seniors
In persons with obesity, even those aged 65-75 years of age, bariatric surgery can reduce long-term cardiovascular events, such as heart failure,...
From the Journals
Fresh data confirm healthy plant foods link to lower diabetes risk
Metabolites contained in whole grains, fruits, and vegetables seem to be the key to reducing risk of developing type 2 diabetes in those who...
From the Journals
The best statins to lower non-HDL cholesterol in diabetes?
Rosuvastatin, simvastatin, and atorvastatin were most effective in reducing levels of non-HDL cholesterol in people with diabetes in a network...
Conference Coverage
Combo of SGLT2 inhibitor + GLP-1 RA boosts diabetes survival
Survival of patients with type 2 diabetes and CVD rose by 80% when they received both an SGLT2 inhibitor and GLP-1 RA, compared with either class...
Guidelines
AHA statement addresses CVD risk in NAFLD
The American Heart Association has issued a new scientific statement addressing cardiovascular risk in nonalcoholic fatty liver disease.
Conference Coverage
Better survival in older cancer patients who take metformin
“It is important to explore optimal dosages that significantly improve cancer outcomes to boost anticancer effect.”
Conference Coverage
High comorbidity rate seen before osteoarthritis diagnosis
More than 40 medical conditions were positively associated with having a new diagnosis of osteoarthritis in a large, nested case-control study.
Conference Coverage
Empagliflozin rapidly improves acute heart failure symptoms in hospitalized patients
Empagliflozin showed symptomatic benefits in patients hospitalized for acute heart failure after 2 weeks in a secondary analysis from the EMPULSE...
Latest News
Racial and ethnic disparities persist in pregnant women with gestational diabetes
From 2014 to 2020, differences in adverse outcomes by race and ethnicity persisted; in comparison with Whites, Black participants were at...
From the Journals
‘Forever chemicals’ exposures may compound diabetes risk
The increased risk of diabetes observed among women exposed to a combination of ‘forever chemicals’ is similar to that associated with overweight...